Our data, however, indicate that changes in the number of returns may not represent locomotor sequelae of ET-1 infusion, such as hyperactivity, as revealed by the absence of group differences in speed profiles, in contrast to earlier reports of ischemia-induced hyperactivity (Plamondon et al., 2008). The gene discussed is EDN1; the disease is ischemia.